Johannes Gutenberg-Universität Mainz
- 6131/39-0
Kommer, Andreas; Holtz, Stefan; Kraus, Daniel et al.
Long-term survival of kidney-transplant recipient with donor-transmitted malignant melanoma after provoked rejectionTRANSPLANT IMMUNOLOGY. Bd. 87. 2024
Beckschulte, Kai; Lederer, Ann-Kathrin; Storz, Maximilian Andreas
Long-term trends in international medical electives fees: a database mining studyBMC MEDICAL EDUCATION. Bd. 24. H. 1. 2024
Wierichs, R. J.; Kramer, E. J.; Reiss, B. et al.
Longevity and risk factors of CAD-CAM manufactured implant-supported all-ceramic crowns- A prospective, multi-center, practice-based cohort studyDENTAL MATERIALS. Bd. 40. H. 11. 2024 S. 1962-1969
Schmalbach, I.; Steudte-Schmiedgen, S.; Osmers, A. et al.
Longitudinal Assessment of Hair Cortisol as a Predictor of Psychological Symptoms During COVID-19PSYCHONEUROENDOCRINOLOGY. Bd. 163. 2024
Wetzel, Simon; Mueller, Alexander; Kohnert, Eva et al.
Longitudinal dynamics of gut bacteriome and mycobiome interactions pre- and post-visceral surgery in Crohn's diseaseFRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY. Bd. 13. 2024
Jezycki, T.; Berlth, F.; Hadzijusufovic, E. et al.
Low psoas muscle index has a negative impact on survival after minimal invasive esophagectomy for cancer in European menEJSO. Bd. 50. H. 10. 2024
Canonico, Mario Enrico; Wang, Cecilia C. Low; Hsia, Judith et al.
Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients After Lower Extremity RevascularizationJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. Bd. 84. H. 9. 2024 S. 801-811
Morrison, Justin T.; Canonico, Mario Enrico; Anand, Sonia S. et al.
Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PADCIRCULATION. Bd. 149. H. 19. 2024 S. 1536-1539
Espinola-Klein, Christine
Lower extremity arterial disease (LEAD)HERZ. Bd. 49. H. 4. 2024 S. 313-318
Protopapa, Maria; Schmaul, Samantha; Schraad, Muriel et al.
Lower leukocytes pretreatment as a possible risk factor for therapy-induced leukopenia in interferon-beta-treated patients with multiple sclerosisTHERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. Bd. 17. 2024